期刊文献+

重组人血管内皮生长因子(VEGF)单克隆抗体的制备 被引量:1

Preparation of monoclonal antibody of VEGF protein
在线阅读 下载PDF
导出
摘要 为制备人血管内皮生长因子(VEGF)单克隆抗体,制备并纯化了VEGF蛋白,通过免疫、细胞融合、筛选等方法获得了能够稳定分泌单克隆抗体的细胞株;采用小鼠腹腔接种法制备腹水,并用G蛋白(Protein G)亲和层析柱对抗体进行了纯化;采用间接ELISA及Western blot实验分别对纯化后的抗体进行了效价测定和特异性验证.结果表明:此方法可成功筛选出能稳定分泌VEGF单克隆抗体的杂交瘤细胞株,纯化后腹水抗体效价为1∶1 024;Western blot检验证实制备的单克隆抗体能特异性识别VEGF蛋白. The aim of this research was to prepare VEGF monoclonal antibody. The recombinant VEGF protein was prepared and purified, and the hybridoma cell lines which secreted stable monoclonal antibodies against VEGF antigen was produced through immunization, cell fusion, screening and other methods. Antibody was isolated using Protein G column. The titer and specificity of monoclonal antibody was analyzed by indirect ELISA and Western blot respectively. Results showed that the hybridoma cell lines which secreted stable monoclonal antibodies against VEGF antigen were successfully screened, and the titer was 1 : 1 024. Western blot analysis showed that the VEGF monoclonal antibody could recognize VEGF protein specifically.
出处 《东北师大学报(自然科学版)》 CAS CSCD 北大核心 2013年第3期126-129,共4页 Journal of Northeast Normal University(Natural Science Edition)
基金 长春市科技发展计划项目(长科技合2010058号) 国家自然科学基金资助项目(81028010)
关键词 VEGF 单克隆抗体 ELISA VEGF protein monoclonal antibody ELISA
  • 相关文献

参考文献9

  • 11.EPELLETIER Y,CAMARA-CLAYETTE V,JIN H, et al. Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments [J]. Cancer Res, 2007,67(3) :1145-1154.
  • 2FERRARA N, HENZEL W. Pituitary follicular cells secret a novel heprin-binding growth factor specific for vascular endothelial cells [J]. Biochem Biophys Res COMMUN, 1989,161 : 851 858.
  • 3YAMAMOTO Y,TOI M,KONDO S,et al. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients [J]. Clin Cancer Res,1996,2(5) :821 - 826.
  • 4H ASEGAWA Y, TAKANASHI S, OKUDERA K, et al. Vascular endothelial growth factor level as a prognostic determinant of small cell lung cancer in Japanese patients [J]. Intern Med, 2005,44( 1):26 34.
  • 5SHIMADA H,TAKEDA A, NABEYA Y, et al. Clinical significance of serum vascular endothelial growth factor in esuphagcal squamous cell carcinoma [J] Cancer,2001,92(3):663-689.
  • 6PAULOVICH A G, HARTWELI. L H. A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage [J]. Ce11,1995,82(5) :841-847.
  • 7KOHLER G, MILSTEIN C. Continuous cultures of fused cells secreting antibody of predefined specificity [J]. Nature, 1975 (256) :495-497.
  • 8王彦敏.血管生成因子VEGF研究进展[J].河北医药,2010,32(11):1456-1458. 被引量:32
  • 9石琦,单冰,高晨,姜慧英,张宝云,韩俊,董小平.血管内皮生长因子(VEGF)单克隆抗体的制备及鉴定[J].细胞与分子免疫学杂志,2008,24(2):142-143. 被引量:1

二级参考文献22

共引文献31

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部